Is your organization actually ready for value-based care?
Value-based care rewards organizations that can measure and manage total cost of care. It punishes the ones that can’t. The difference between those two outcomes is almost never clinical quality — it is whether the infrastructure to see your own performance was in place before the contract was signed.
1. Can you see your total cost of care today?
Under fee-for-service you only need to know what you billed. Under a risk arrangement you need to know what the patient cost, including every service delivered somewhere else. That means claims data from the payer, and the ability to actually work with it.
- Do you receive complete claims or encounter files, and how current are they?
- Can you attribute spend to a patient panel and a responsible clinician?
- Do you know your per-member-per-month cost by line of business?
- Can you separate what you control from what you don’t?
If you cannot produce your own cost of care before signing, you are agreeing to be measured by a number only the payer can calculate.
2. Is your attribution methodology written down and understood?
Attribution decides which patients count as yours, and it drives everything downstream. Two reasonable-sounding methodologies can produce panels that differ by a third. Read the methodology in the contract, model it against your actual patients, and confirm you can reproduce the payer’s list.
3. Do you have care management, or just intentions?
Shared savings come from changing utilization — avoidable admissions, readmissions, emergency department visits, and gaps in chronic disease management. That work requires named people doing it as their job.
- Who identifies rising-risk patients, and from what data?
- What happens in the 48 hours after a member is discharged?
- How are gaps in care surfaced to the clinician at the point of care?
An organization with excellent physicians and no care management infrastructure will produce excellent care and disappointing savings.
4. Are the contract terms survivable?
The clinical readiness conversation gets all the attention, and the contract quietly decides the outcome. Look hard at the risk corridor, the quality gate, and how the benchmark is set and rebased.
- Is there a stop-loss or risk corridor, and where does it cap your exposure?
- Does a quality gate withhold savings you have genuinely earned?
- How is the benchmark trended, and does strong performance ratchet it against you next cycle?
- What are the data delivery obligations, and what is the remedy if the payer misses them?
That last one matters more than it looks. A risk contract without an enforceable data obligation asks you to manage a number you cannot see.
Where this usually lands
Most organizations are further along clinically than they are analytically. The honest answer is often that the first agreement should be upside-only, with a defined path to downside risk once the reporting is proven against real claims for a full year.
There is no penalty for taking risk a year later than you could have. There is a substantial one for taking it a year earlier.